Immunotherapy
414 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
414
Total Reports
24
Deaths Reported
580.0%
Death Rate
Active Ingredients
Immunotherapy
Administration Routes
UnknownOralSublingualParenteralSubcutaneousOtherIntradermalTransdermal
Species Affected
Dog 394
Cat 20
Most Affected Breeds
Retriever - Labrador 55
Retriever - Golden 29
Shepherd Dog - German 23
Terrier - Bull - American Pit 21
Bulldog - French 16
Bulldog 14
Terrier - Yorkshire 14
Domestic Shorthair 12
Terrier - West Highland White 11
Shih Tzu 10
Most Reported Reactions
Lack of efficacy - NOS 61
Other abnormal test result NOS 43
Vomiting 38
INEFFECTIVE, ATOPY CONTROL 37
INEFFECTIVE, LOSS OF EFFECT 35
Lethargy (see also Central nervous system depression in 'Neurological') 34
Diarrhoea 28
Leucopenia NOS 23
Neutropenia 22
Elevated alanine aminotransferase (ALT) 19
Skin disorders NOS 18
Death by euthanasia 17
Outcome Breakdown
Ongoing
256 (61.8%)
Outcome Unknown
70 (16.9%)
Recovered/Normal
60 (14.5%)
Euthanized
17 (4.1%)
Died
7 (1.7%)
Recovered with Sequela
4 (1.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.